NCT07019818View on ClinicalTrials.gov

Esmolol Versus Sufentanil on the Quality of Post-cholecystectomy Recovery Laparoscopic Anaesthesia With Orotracheal Intubation on an Outpatient Basis

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 2, 2025

Primary Completion Date

January 4, 2028

Study Completion Date

January 5, 2028

Conditions
Laparoscopic Cholecystectomy Surgery
Interventions
DRUG

Esmolol Hcl 10Mg/Ml Inj

Esmolol is an injectable cardioselective beta-blocker, preferentially inhibiting beta-1 adrenergic receptors, while avoiding an increase in peripheral vascular resistance.

DRUG

Sufentanil 5 mcg

Sufentanil is a synthetic opioid with the pharmacological properties of a µ-receptor agonist.

All Listed Sponsors
lead

University Hospital, Limoges

OTHER